Universitätsklinikum Düsseldorf

Survival Analysis After Neoadjuvant Chemotherapy With Trastuzumab or Lapatinib in Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer in the GeparQuinto (G5) Study (GBG 44) (2018) Untch M, Von Minckwitz G, Gerber B, Schem C, Rezai M, Fasching P, Tesch H, et al. Journal article Use of Granulocyte-colony Stimulating Factor During Chemotherapy and Its Association With CA27.29 and Circulating Tumor Cells-Results From the SUCCESS A Trial (2018) Hepp P, Fasching P, Beckmann M, Fehm T, Salmen J, Hagenbeck C, Jaeger B, et al. Journal article Trastuzumab versus observation for HER2 nonamplified early breast cancer with circulating tumor cells (EORTC 90091-10093, BIG 1-12, Treat CTC): a randomized phase II trial (2018) Ignatiadis M, Litiere S, Rothe F, Riethdorf S, Proudhon C, Fehma T, Aalders K, et al. Journal article Treatment and outcomes of patients in the Brain Metastases in Breast Cancer Network Registry (2018) Witzel I, Laakmann E, Weide R, Neunhoeffer T, Park-Simon TJ, Schmidt M, Fasching P, et al. Journal article Update Breast Cancer 2018 (Part 2) - Advanced Breast Cancer, Quality of Life and Prevention (2018) Schneeweiss A, Lux MP, Janni W, Hartkopf AD, Nabieva N, Taran FA, Overkamp F, et al. Journal article Update Breast Cancer 2018 (Part 1) - Primary Breast Cancer and Biomarkers (2018) Taran FA, Schneeweiss A, Lux MP, Janni W, Hartkopf AD, Nabieva N, Overkamp F, et al. Journal article Update Breast Cancer 2018 (Part 4) - Genomics, Individualized Medicine and Immune Therapies - in the Middle of a New Era: Treatment Strategies for Advanced Breast Cancer (2018) Mueller V, Woeckel A, Lux MP, Janni W, Hartkopf AD, Nabieva N, Taran FA, et al. Journal article Update Breast Cancer 2018 (Part 3) - Genomics, Individualized Medicine and Immune Therapies - in the Middle of a New Era: Prevention and Treatment Strategies for Early Breast Cancer (2018) Woeckel A, Lux MP, Janni W, Hartkopf AD, Nabieva N, Taran FA, Overkamp F, et al. Journal article Neoadjuvant chemotherapy for breast cancer-background for the indication of locoregional treatment (2018) Krug D, Baumann R, Budach W, Dunst J, Feyer P, Fietkau R, Haase W, et al. Journal article Interdisciplinary Diagnosis, Therapy and Follow-up of Patients with Endometrial Cancer. Guideline (S3-Level, AWMF Registry Number 032/034-OL, April 2018) - Part 2 with Recommendations on the Therapy and Follow-up of Endometrial Cancer, Palliative Care, Psycho-oncological/Psychosocial Care/Rehabilitation/Patient Information and Healthcare Facilities (2018) Emons G, Steiner E, Vordermark D, Uleer C, Bock N, Paradies K, Ortmann O, et al. Journal article